2007糖尿病与慢性肾脏疾病临床操作指南与推荐.pdf

Blood Purif 2007;25:112–114 Published online: December 14, 2006 DOI: 10.1159/000096407 The New KDOQITM Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and CKD Robert G. Nelson a Katherine R. Tuttle b for the National Kidney Foundation a Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Ariz. , and b Providence Medical Research Center, Spokane, Wash. , USA Key Words Nearly 21 million persons in the US have diabetes. Chronic kidney disease Diabetes Guidelines, KDOQI About 5–10% of them have type 1 diabetes, which devel- ops as a consequence of the body’s failure to produce in- sulin. Most others have type 2 diabetes, which develops Abstract because of the body’s failure to properly use the insulin it Background/Aims: The National Kidney Foundation (NKF) produces. Projections on the future burden of diabetes recently published new guidelines and clinical practice rec- suggest that the prevalence will increase 165% between ommendations for the diagnosis and management of pa- 2000 and 2050, with the greatest increases in the popula- tients with diabetes and chronic kidney disease (CKD). Meth- tion over 75 years old and among African-Americans [1] . ods: Guidelines were developed using an evidence-based Children are also increasingly affected by diabetes. Most approach. When suff